Publication of prospectus
Oncology Venture Sweden AB ("Oncology Venture") hereby publishes prospectus regarding the rights issue starting March 16, 2017. The prospectus is available via the Company´s (www.oncologyventure.com), AktieTorgets (www.aktietorget.se) and Sedermera Fondkommissions (www.sedermera.se) respective websites. Teaser and subscription forms will be published in connection with the start of the subscription period.The subscription period runs until 30 March, 2017. Fully subscribed rights issue provides Oncology Venture with approximately SEK 52.9 million before issuing costs. Beforehand, the company